6 assets in Cerebellar Degeneration

Therapeutic assets addressing Cerebellar Degeneration, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)
Camustine Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)
Cytarabine Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)
Etoposide Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)
Melphalan Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)
Prednisone Cerebellar Degeneration	Fred Hutchinson Cancer Center	P2	CCC (53)